DRD
AUTL

Dennis R. Delaney’s Autolus Therapeutics AUTL Stock Holding History

Dennis R. Delaney’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.1K Hold
24,000
– – 0.01% 60
2025
Q4 		$47.8K Hold
24,000
– – 0.02% 49
2025
Q3 		$39.1K Hold
24,000
– – 0.02% 49
2025
Q2 		$54.7K Buy
+24,000
New +$39.7K 0.03% 49

Other funds holding AUTL

MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dennis R. Delaney's AUTL Position: Q1 2026 in Review

Dennis R. Delaney held its Autolus Therapeutics (AUTL) position steady in Q1 2026 at 24,000 shares worth $33.1K. The position accounts for 0.01% of the portfolio, ranked #60.

Dennis R. Delaney first reported a position in AUTL in Q2 2025 and has held it in 4 quarters since. The position peaked at $54.7K in Q2 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q1 2026.

  • Dennis R. Delaney held 24,000 shares of Autolus Therapeutics worth $33.1K as of Q1 2026.
  • Dennis R. Delaney left its Autolus Therapeutics share count unchanged in Q1 2026.
  • Autolus Therapeutics made up 0.01% of Dennis R. Delaney's portfolio in Q1 2026, its #60 holding.
  • Dennis R. Delaney first reported a position in Autolus Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Dennis R. Delaney's Autolus Therapeutics position peaked at $54.7K in Q2 2025.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2026.

Based on Dennis R. Delaney's 13F filing for Q1 2026, filed 14 May 2026.